Verge Genomics
San Francisco
About Verge Genomics
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $134.1M
- Funding stage: Late Stage Venture
- Last round: Series Unknown (Jul 2023)
- Website: vergegenomics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care, Machine Learning, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/verge-genomics-85445 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.